MetMaxStruct: A Tversky-similarity-based strategy for analysing the (sub)structural similarities of drugs and endogenous metabolites

Frontiers in Pharmacology

Volumn 7, Issue AUG, 2016, Pages

  O'Hagan, Steve ^a   Kell, Douglas B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cheminformatics; Drug transporters; Endogenites; Metabolomics; Tversky similarity

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DRUG; RIBOFLAVIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMOINFORMATICS; CHEMOTAXONOMY; DRUG STRUCTURE; INFORMATION SCIENCE; METABOLITE; METABOLOMICS; MOLECULAR WEIGHT; TANIMOTO SIMILARITY; TVERSKY SIMILARITY;

EID: 84988662292     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00266     Document Type: Article

References (135)

1. Backman, T. W. H., Cao, Y., and Girke, T. (2011). ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 39, W486-W491. doi: 10.1093/nar/gkr320
2. Balcan, M. F., and Blum, A. (2010). A discriminative model for semi-supervised learning. J. ACM 57, 671-680. doi: 10.1145/1706591.1706599
3. Baldi, P., and Nasr, R. (2010). When is chemical similarity significant? The statistical distribution of chemical similarity scores and its extreme values. J. Chem. Inf. Model. 50, 1205-1222. doi: 10.1021/ci100010v
4. Beisken, S., Meinl, T., Wiswedel, B., De Figueiredo, L. F., Berthold, M., Steinbeck, C., et al. (2013). KNIME-CDK: Workflow-driven cheminformatics. BMC Bioinformatics 14:257. doi: 10.1186/1471-2105-14-257
5. Bender, A., and Glen, R. C. (2004). Molecular similarity: a key technique in molecular informatics. Org. Biomol. Chem. 2, 3204-3218. doi: 10.1039/b409813g
6. Bender, A., Jenkins, J. L., Li, Q. L., Adams, S. E., Cannon, E. O., and Glen, R. C. (2006). Molecular similarity: advances in methods, applications and validations in virtual screening and qsar. Ann. Rep. Comput. Chem. 2, 141-168. doi: 10.1016/S1574-1400(06)02009-3
7. Bengio, Y. (2009). Learning deep architectures for AI. Found Trends Mach. Learn 2, 1-127. doi: 10.1561/2200000006
8. Berenger, F., Voet, A., Lee, X. Y., and Zhang, K. Y. J. (2014). A rotation-translation invariant molecular descriptor of partial charges and its use in ligand-based virtual screening. J. Cheminform. 6:23. doi: 10.1186/1758-2946-6-23
9. Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., et al. (2008). "KNIME: the Konstanz Information Miner," in Data Analysis, Machine Learning and Applications, eds C. Preisach, H. Burkhardt, L. Schmidt-Thieme and R. Decker (Berlin: Springer), 319-326.
10. Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., and Hopkins, A. L. (2012). Quantifying the chemical beauty of drugs. Nat. Chem. 4, 90-98. doi: 10.1038/nchem.1243
11. Broadhurst, D., and Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2, 171-196. doi: 10.1007/s11306-006-0037-z
12. Broomhead, D. S., and Lowe, D. (1988). Multivariable function interpolation and adaptive networks. Complex Syst. 2, 321-355.
13. Bunke, H. (1997). On a relation between graph edit distance and maximum common subgraph. Patt. Recogn. Lett. 18, 689-694. doi: 10.1016/S0167-8655(97)00060-3
14. Caldinelli, L., Molla, G., Bracci, L., Lelli, B., Pileri, S., Cappelletti, P., et al. (2010). Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment. Protein Sci. 19, 1500-1512. doi: 10.1002/pro.429
15. César-Razquin, A., Snijder, B., Frappier-Brinton, T., Isserlin, R., Gyimesi, G., Bai, X., et al. (2015). A call for systematic research on solute carriers. Cell 162, 478-487. doi: 10.1016/j.cell.2015.07.022
16. Chapelle, O., Schölkopf, B., and Zien, A. (eds.). (2010). Semi-Supervised Learning. Cambridge, MA: MIT Press.
17. Chen, J., Swamidass, S. J., Dou, Y., Bruand, J., and Baldi, P. (2005). ChemDB: a public database of small molecules and related chemoinformatics resources. Bioinformatics 21, 4133-4139. doi: 10.1093/bioinformatics/bti683
18. Cherkasov, A. (2006). Can 'Bacterial-Metabolite-Likeness' model improve odds of 'in silico' antibiotic discovery? J. Chem. Inf. Model. 46, 1214-1222. doi: 10.1021/ci050480j
19. Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., et al. (2014). QSAR modeling: where have you been? where are you going to? J. Med. Chem. 57, 4977-5010. doi: 10.1021/jm4004285
20. Demiriz, A., Bennett, K., and Embrechts, M. J. (1999). "Semi-supervised clustering using genetic algorithms," in Intelligent engineering systems through artificial neural networks, eds C.H. Dagli, A.L. Buczak, J. Ghosh, M.J. Embrechts and O. Ersoy (New York, NY: ASME Press), 809-814.
21. Dixon, S. L., and Koehler, R. T. (1999). The hidden component of size in two-dimensional fragment descriptors: side effects on sampling in bioactive libraries. J. Med. Chem. 42, 2887-2900. doi: 10.1021/jm980708c
22. Dobson, P. D., and Kell, D. B. (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat. Rev. Drug. Discov. 7, 205-220. doi: 10.1038/nrd2438
23. Dobson, P. D., Patel, Y., and Kell, D. B. (2009). "Metabolite-likeness" as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov. Today 14, 31-40. doi: 10.1016/j.drudis.2008.10.011
24. Dobson, P., Lanthaler, K., Oliver, S. G., and Kell, D. B. (2009). Implications of the dominant role of cellular transporters in drug uptake. Curr. Top. Med. Chem. 9, 163-184. doi: 10.2174/156802609787521616
25. Durant, J. L., Leland, B. A., Henry, D. R., and Nourse, J. G. (2002). Reoptimization of MDL keys for use in drug discovery. J. Chem. Inf. Comput. Sci. 42, 1273-1280. doi: 10.1021/ci010132r
26. Ebalunode, J. O., Ouyang, Z., Liang, J., and Zheng, W. (2008). Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques. J. Chem. Inf. Model. 48, 889-901. doi: 10.1021/ci700368p
27. Ecker, G., and Chiba, P. (eds.). (2009). Transporters as Drug Carriers: Structure, Function, Substrates. Weinheim: Wiley/VCH.
28. Ecker, G. F. (2014). Transmembrane drug transporter-taxonomy, assays, and their role in drug discovery. Drug Discov. Today Technol. 12, e35-e36. doi: 10.1016/j.ddtec.2014.04.002
29. Eckert, H., and Bajorath, J. (2007). Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov. Today 12, 225-233. doi: 10.1016/j.drudis.2007.01.011
30. Erhan, D., Bengio, Y., Courville, A., Manzagol, P. A., Vincent, P., and Bengio, S. (2010). Why does unsupervised pre-training help deep learning? J. Mach. Learn. Res. 11, 625-660.
31. Ertl, P., Roggo, S., and Schuffenhauer, A. (2008). Natural product-likeness score and its application for prioritization of compound libraries. J. Chem. Inf. Model. 48, 68-74. doi: 10.1021/ci700286x
32. Everitt, B. S. (1993). Cluster Analysis. London: Edward Arnold.
33. Flower, D. R. (1998). On the properties of bit string-based measures of chemical similarity. J. Chem. Inf. Comp. Sci. 38, 379-386. doi: 10.1021/ci970437z
34. Fromm, M. F., and Kim, R. B. (eds.). (2011). Drug Transporters. Berlin: Springer.
35. Gabay, S., and Harris, S. R. (1965). Studies of flavin adenine dinucleotide-requiring enzymes and phenothiazines-I. interactions of chlorpromazine and D-amino acid oxidase. Biochem. Pharmacol. 14, 17-26. doi: 10.1016/0006-2952(65)90053-5
36. Gallegos-Saliner, A., Poater, A., Jeliazkova, N., Patlewicz, G., and Worth, A. P. (2008). Toxmatch-a chemical classification and activity prediction tool based on similarity measures. Regul. Toxicol. Pharmacol. 52, 77-84. doi: 10.1016/j.yrtph.2008.05.012
37. Gan, S., Cosgrove, D. A., Gardiner, E. J., and Gillet, V. J. (2014). Investigation of the use of spectral clustering for the analysis of molecular data. J. Chem. Inf. Model. 54, 3302-3319. doi: 10.1021/ci500480b
38. Gasteiger, J. (ed.). (2003). Handbook of Chemoinformatics: From Data to Knowledge. Weinheim: Wiley/VCH.
39. Geitmann, M., Elinder, M., Seeger, C., Brandt, P., De Esch, I. J. P., Danielson, U. H., et al. (2011). Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening. J. Med. Chem. 54, 699-708. doi: 10.1021/jm1010513
40. Giacomini, K. M., and Huang, S. M. (2013). Transporters in drug development and clinical pharmacology. Clin. Pharmacol. Ther. 94, 3-9. doi: 10.1038/clpt.2013.86
41. Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., et al. (2010). Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215-236. doi: 10.1038/nrd3028
42. Gründemann, D. (2012). The ergothioneine transporter controls and indicates ergothioneine activity-a review. Prev. Med. 54(Suppl.), S71-S74. doi: 10.1016/j.ypmed.2011.12.001
43. Gründemann, D., Harlfinger, S., Golz, S., Geerts, A., Lazar, A., Berkels, R., et al. (2005). Discovery of the ergothioneine transporter. Proc. Natl. Acad. Sci. U.S.A. 102, 5256-5261. doi: 10.1073/pnas.0408624102
44. Gupta, S., and Aires-De-Sousa, J. (2007). Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness. Mol. Divers. 11, 23-36. doi: 10.1007/s11030-006-9054-0
45. Hall, L. H., Kier, L. B., and Brown, B. B. (1995). Molecular similarity based on novel atom-type electrotopological state indexes. J. Chem. Inf. Comp. Sci. 35, 1074-1080. doi: 10.1021/ci00028a019
46. Handl, J., and Knowles, J. (2006). "Semi-supervised feature selection via multiobjective optimization," in IEEE Proceedings of International Joint Conference on Neural Network (Vancouver, BC), 3319-3326.
47. Handl, J., and Knowles, J. (2007). An evolutionary approach to multiobjective clustering. IEEE Trans. Evol. Comput. 11, 56-76. doi: 10.1109/TEVC.2006.877146
48. Handl, J., Knowles, J., and Kell, D. B. (2005). Computational cluster validation in post-genomic data analysis. Bioinformatics 21, 3201-3212. doi: 10.1093/bioinformatics/bti517
49. Hastie, T., Tibshirani, R., and Friedman, J. (2009). The Elements Of Statistical Learning: Data Mining, Inference and Prediction, 2nd Edn. Berlin: Springer-Verlag.
50. Hediger, M. A., Clémencon, B., Burrier, R. E., and Bruford, E. A. (2013). The ABCs of membrane transporters in health and disease (SLC series): Introduction. Mol. Aspects Med. 34, 95-107. doi: 10.1016/j.mam.2012.12.009
51. Herrgård, M. J., Swainston, N., Dobson, P., Dunn, W. B., Arga, K. Y., Arvas, M., et al. (2008). A consensus yeast metabolic network obtained from a community approach to systems biology. Nat. Biotechnol. 26, 1155-1160. doi: 10.1038/nbt1492
52. Hinton, G. E. (2007). Learning multiple layers of representation. Trends Cogn. Sci. 11, 428-434. doi: 10.1016/j.tics.2007.09.004
53. Hinton, G. E., Osindero, S., and Teh, Y. W. (2006). A fast learning algorithm for deep belief nets. Neural Comput. 18, 1527-1554. doi: 10.1162/neco.2006.18.7.1527
54. Hinton, G. E., and Salakhutdinov, R. R. (2006). Reducing the dimensionality of data with neural networks. Science 313, 504-507. doi: 10.1126/science.1127647
55. Holliday, J. D., Hu, C. Y., and Willett, P. (2002). Grouping of coefficients for the calculation of inter-molecular similarity and dissimilarity using 2D fragment bit-strings. Comb. Chem. High Throughput Screen. 5, 155-166. doi: 10.2174/1386207024607338
56. Hotelling, H. (1933). Analysis of a complex of statistical variables into principal components. J. Educ. Psychol. 24, 417-441. doi: 10.1037/h0071325
57. Irwin, J. J. (2008). Using ZINC to acquire a virtual screening library. Curr Protoc. Bioinformatics Chapter 14, Unit 14.16. doi: 10.1002/0471250953.bi1406s22
58. Irwin, J. J., and Shoichet, B. K. (2005). ZINC-a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177-182. doi: 10.1021/ci049714+
59. Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., and Coleman, R. G. (2012). ZINC: a free tool to discover chemistry for biology. J. Chem. Inf. Model. 52, 1757-1768. doi: 10.1021/ci3001277
60. Ishikawa, T., Kim, R. B., and König, J. (eds.). (2013). Pharmacogenomics of Human Drug Transporters: Clinical Impacts. New York, NY: Wiley.
61. Iwana, S., Kawazoe, T., Park, H. K., Tsuchiya, K., Ono, K., Yorita, K., et al. (2008). Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia. J. Enzyme Inhib. Med. Chem. 23, 901-911. doi: 10.1080/14756360701745478
62. Iwasa, S., Tabara, H., Song, Z., Nakabayashi, M., Yokoyama, Y., and Fukushima, T. (2011). Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate. Yakugaku Zasshi 131, 1111-1116. doi: 10.1248/yakushi.131.1111
63. Jayaseelan, K. V., Moreno, P., Truszkowski, A., Ertl, P., and Steinbeck, C. (2012). Natural product-likeness score revisited: an open-source, open-data implementation. BMC Bioinformatics 13:106. doi: 10.1186/1471-2105-13-106
64. Johnson, M. A., and Maggiora, G. M. (eds.). (1990). Concepts and Applications of Molecular Similarity. New York, NY: Wiley.
65. Karakoc, E., Sahinalp, S. C., and Cherkasov, A. (2006). Comparative QSAR-and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds. J. Chem. Inf. Model. 46, 2167-2182. doi: 10.1021/ci0601517
66. Kell, D. B. (2013). Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening, and knowledge of transporters: where drug discovery went wrong and how to fix it. FEBS J. 280, 5957-5980. doi: 10.1111/febs.12268
67. Kell, D. B. (2015a). The transporter-mediated cellular uptake of pharmaceutical drugs is based on their metabolite-likeness and not on their bulk biophysical properties: Towards a systems pharmacology. Perspect. Sci. 6, 66-83. doi: 10.1016/j.pisc.2015.06.004
68. Kell, D. B. (2015b). What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible? Trends Pharmacol. Sci. 36, 15-21.
69. Kell, D. B. (2016a, August 11). How drugs pass through biological cell membranes-a paradigm shift in our understanding? Beilstein Magazine 2.
70. Kell, D. B. (2016b). Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness. Nat. Rev. Drug Discov. 15, 143-144. doi: 10.1038/nrd.2015.44
71. Kell, D. B., and Dobson, P. D. (2009). "The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology," in Proc Int Beilstein Symposium on Systems Chemistry, eds M. G. Hicks and C. Kettner (Berlin: Logos Verlag), 149-168. Available online at: http://www.beilstein-institut.de/download/628/09_kell.pdf
72. Kell, D. B., Dobson, P. D., Bilsland, E., and Oliver, S. G. (2013). The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discov. Today 18, 218-239. doi: 10.1016/j.drudis.2012.11.008
73. Kell, D. B., Dobson, P. D., and Oliver, S. G. (2011). Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discov. Today 16, 704-714. doi: 10.1016/j.drudis.2011.05.010
74. Kell, D. B., and Goodacre, R. (2014). Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov. Today 19, 171-182. doi: 10.1016/j.drudis.2013.07.014
75. Kell, D. B., and Oliver, S. G. (2014). How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Front. Pharmacol. 5:231. doi: 10.3389/fphar.2014.00231
76. Kell, D. B., Swainston, N., Pir, P., and Oliver, S. G. (2015). Membrane transporter engineering in industrial biotechnology and whole-cell biocatalysis. Trends Biotechnol. 33, 237-246. doi: 10.1016/j.tibtech.2015.02.001
77. Kingma, D. P., Rezendey, D. J., Mohamedy, S., and Welling, M. (2014). Semi-supervised learning with deep generative models. Proc. Adv. Neural Inf. Proc. 27, 3581-3589.
78. Koepsell, H. (2013). The SLC22 family with transporters of organic cations, anions and zwitterions. Mol. Aspects Med. 34, 413-435. doi: 10.1016/j.mam.2012.10.010
79. Landrum, G. A., and Stiefl, N. (2012). Is that a scientific publication or an advertisement? Reproducibility, source code and data in the computational chemistry literature. Future Med. Chem. 4, 1885-1887. doi: 10.4155/fmc.12.160
80. Landrum, G., Lewis, R., Palmer, A., Stiefl, N., and Vulpetti, A. (2011). Making sure there's a "give" associated with the "take": producing and using open-source software in big pharma. J. Cheminform. 3:O3. doi: 10.1186/1758-2946-3-s1-o3
81. Lanthaler, K., Bilsland, E., Dobson, P. D., Moss, H. J., Pir, P., Kell, D. B., et al. (2011). Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast. BMC Biol. 9:70. doi: 10.1186/1741-7007-9-70
82. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., et al. (2014). DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091-D1097. doi: 10.1093/nar/gkt1068
83. Lecun, Y., Bengio, Y., and Hinton, G. (2015). Deep learning. Nature 521, 436-444. doi: 10.1038/nature14539
84. Lucas, X., Senger, C., Erxleben, A., Grüning, B. A., Doring, K., Mosch, J., et al. (2013). StreptomeDB: a resource for natural compounds isolated from Streptomyces species. Nucleic Acids Res. 41, D1130-D1136. doi: 10.1093/nar/gks1253
85. Maggiora, G. M., and Shanmugasundaram, V. (2011). Molecular similarity measures. Methods Mol. Biol. 672, 39-100. doi: 10.1007/978-1-60761-839-3_2
86. Maggiora, G., Vogt, M., Stumpfe, D., and Bajorath, J. (2014). Molecular similarity in medicinal chemistry. J. Med. Chem. 57, 3186-3204. doi: 10.1021/jm401411z
87. Maldonado, A. G., Doucet, J. P., Petitjean, M., and Fan, B. T. (2006). Molecular similarity and diversity in chemoinformatics: from theory to applications. Mol. Divers. 10, 39-79. doi: 10.1007/s11030-006-8697-1
88. Marín, R. M., Aguirre, N. F., and Daza, E. E. (2008). Graph theoretical similarity approach to compare molecular electrostatic potentials. J. Chem. Inf. Model. 48, 109-118. doi: 10.1021/ci7001878
89. Mazanetz, M. P., Marmon, R. J., Reisser, C. B. T., and Morao, I. (2012). Drug discovery applications for KNIME: an open source data mining platform. Curr. Top. Med. Chem. 12, 1965-1979. doi: 10.2174/156802612804910331
90. Medina-Franco, J. L., and Maggiora, G. M. (2014). "Molecular similarity analysis," in Chemoinformatics for Drug Discovery, ed J. Bajorath (Hoboken, NJ: Wiley), 343-399.
91. Mendes, P., Oliver, S. G., and Kell, D. B. (2015). Fitting transporter activities to cellular drug concentrations and fluxes: why the bumblebee can fly. Trends Pharmacol. Sci. 36, 710-723. doi: 10.1016/j.tips.2015.07.006
92. Moody, J., and Darken, C. (1989). Fast learning in networks of locally-tuned processing units. Neural Comput. 1, 281-294. doi: 10.1162/neco.1989.1.2.281
93. Nasr, R. J., Swamidass, S. J., and Baldi, P. F. (2009). Large scale study of multiple-molecule queries. J. Cheminform. 1:7. doi: 10.1186/1758-2946-1-7
94. Neal, M. J., Goodacre, R., and Kell, D. B. (1994). "On the analysis of pyrolysis mass spectra using artificial neural networks. Individual input scaling leads to rapid learning," in Proceedings of the World Congress on Neural Networks: International Neural Network Society (San Diego), 318-323.
95. Nicholls, A., Mcgaughey, G. B., Sheridan, R. P., Good, A. C., Warren, G., Mathieu, M., et al. (2010). Molecular shape and medicinal chemistry: a perspective. J. Med. Chem. 53, 3862-3886. doi: 10.1021/jm900818s
96. Nigam, S. K. (2015). What do drug transporters really do? Nat. Rev. Drug Discov. 14, 29-44. doi: 10.1038/nrd4461
97. O'Hagan, S., and Kell, D. B. (2015a). The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities PeerJ. 3:E1405. doi: 10.7717/peerj.1405
98. O'Hagan, S., and Kell, D. B. (2015b). Software review: the KNIME workflow environment and its applications in Genetic Programming and machine learning. Genetic Progr. Evol. Mach. 16, 387-391. doi: 10.1007/s10710-015-9247-3
99. O'Hagan, S., and Kell, D. B. (2015c). Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites. Front. Pharmacol. 6:105. doi: 10.3389/fphar.2015.00105
100. O'Hagan, S., Swainston, N., Handl, J., and Kell, D. B. (2015). A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs. Metabolomics 11, 323-339. doi: 10.1007/s11306-014-0733-z
101. Palsson, B. Ø. (2015). Systems Biology: Constraint-Based Reconstruction and Analysis. Cambridge: Cambridge University Press.
102. Paolini, G. V., Shapland, R. H., Van Hoorn, W. P., Mason, J. S., and Hopkins, A. L. (2006). Global mapping of pharmacological space. Nat. Biotechnol. 24, 805-815. doi: 10.1038/nbt1228
103. Peironcely, J. E., Reijmers, T., Coulier, L., Bender, A., and Hankemeier, T. (2011). Understanding and classifying metabolite space and metabolite-likeness. PLoS ONE 6:e28966. doi: 10.1371/journal.pone.0028966
104. Pelliccione, N., Pinto, J., Huang, Y. P., and Rivlin, R. S. (1983). Accelerated development of riboflavin deficiency by treatment with chlorpromazine. Biochem. Pharmacol. 32, 2949-2953. doi: 10.1016/0006-2952(83)90401-X
105. Petrone, P. M., Simms, B., Nigsch, F., Lounkine, E., Kutchukian, P., Cornett, A., et al. (2012). Rethinking molecular similarity: comparing compounds on the basis of biological activity. ACS Chem. Biol. 7, 1399-1409. doi: 10.1021/cb3001028
106. Pinto, J., Huang, Y. P., and Rivlin, R. S. (1981). Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline. J. Clin. Invest. 67, 1500-1506. doi: 10.1172/JCI110180
107. Riniker, S., Fechner, N., and Landrum, G. A. (2013). Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing. J. Chem. Inf. Model. 53, 2829-2836. doi: 10.1021/ci400466r
108. Riniker, S., and Landrum, G. A. (2013). Open-source platform to benchmark fingerprints for ligand-based virtual screening. J. Cheminform. 5:26. doi: 10.1186/1758-2946-5-26
109. Riniker, S., Wang, Y., Jenkins, J. L., and Landrum, G. A. (2014). Using information from historical high-throughput screens to predict active compounds. J. Chem. Inf. Model. 54, 1880-1891. doi: 10.1021/ci500190p
110. Rouvray, D. H. (1992). Definition and role of similarity concepts in the chemical and physical sciences. J. Chem. Inf. Comp. Sci. 32, 580-586. doi: 10.1021/ci00010a002
111. Rupp, M., Schneider, P., and Schneider, G. (2009). Distance phenomena in high-dimensional chemical descriptor spaces: consequences for similarity-based approaches. J. Comput. Chem. 30, 2285-2296.
112. Ruusmann, V., Sild, S., and Maran, U. (2014). QSAR DataBank-an approach for the digital organization and archiving of QSAR model information. J. Cheminform. 6:25. doi: 10.1186/1758-2946-6-25
113. Sahoo, S., Aurich, M. K., Jonsson, J. J., and Thiele, I. (2014). Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease. Front. Physiol. 5:91. doi: 10.3389/fphys.2014.00091
114. Salim, N., Holliday, J., and Willett, P. (2003). Combination of fingerprint-based similarity coefficients using data fusion. J. Chem. Inf. Comp. Sci. 43, 435-442. doi: 10.1021/ci025596j
115. Saubern, S., Guha, R., and Baell, J. B. (2011). KNIME workflow to assess PAINS filters in SMARTS format. comparison of RDKit and indigo cheminformatics libraries. Mol. Inform. 30, 847-850. doi: 10.1002/minf.201100076
116. Sedykh, A., Fourches, D., Duan, J. M., Hucke, O., Garneau, M., Zhu, H., et al. (2013). Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm. Res. 30, 996-1007. doi: 10.1007/s11095-012-0935-x
117. Senger, S. (2009). Using tversky similarity searches for core hopping: finding the needles in the haystack. J. Chem. Inf. Model. 49, 1514-1524. doi: 10.1021/ci900092y
118. Sneath, P. H. A., and Sokal, R. R. (1973). Numerical Taxonomy. San Francisco, CA: Freeman.
119. Sterling, T., and Irwin, J. J. (2015). ZINC 15-ligand discovery for everyone. J. Chem. Inf. Model. 55, 2324-2337. doi: 10.1021/acs.jcim.5b00559
120. Sugiyama, Y., and Steffansen, B. (eds.). (2013). Transporters in Drug Development: Discovery, Optimization, Clinical Study and Regulation. New York, NY: AAPS/Springer.
121. Swainston, N., Mendes, P., and Kell, D. B. (2013). An analysis of a 'community-driven' reconstruction of the human metabolic network. Metabolomics 9, 757-764. doi: 10.1007/s11306-013-0564-3
122. Swamidass, S. J., and Baldi, P. (2007). Bounds and algorithms for fast exact searches of chemical fingerprints in linear and sublinear time. J. Chem. Inf. Model. 47, 302-317. doi: 10.1021/ci600358f
123. Thiele, I., Swainston, N., Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., et al. (2013). A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425. doi: 10.1038/nbt.2488
124. Tomei, S., Yuasa, H., Inoue, K., and Watanabe, J. (2001). Transport functions of riboflavin carriers in the rat small intestine and colon: site difference and effects of tricyclic-type drugs. Drug Deliv. 8, 119-124. doi: 10.1080/107175401316906874
125. Tversky, A. (1977). Features of Similarity. Psychol. Rev. 84, 327-352. doi: 10.1037/0033-295X.84.4.327
126. Walters, W. P. (2012). Going further than Lipinski's rule in drug design. Exp Opin. Drug Discov. 7, 99-107. doi: 10.1517/17460441.2012.648612
127. Wang, Y. A., Eckert, H., and Bajorath, J. (2007). Apparent asymmetry in fingerprint similarity searching is a direct consequence of differences in bit densities and molecular size. Chem. Med. Chem. 2, 1037-1042. doi: 10.1002/cmdc.200700050
128. Wang, Y., and Bajorath, J. (2008). Balancing the influence of molecular complexity on fingerprint similarity searching. J. Chem. Inf. Model. 48, 75-84. doi: 10.1021/ci700314x
129. Willett, P. (2006). Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11, 1046-1053. doi: 10.1016/j.drudis.2006.10.005
130. Willett, P. (2014). The calculation of molecular structural similarity: principles and practice. Mol. Inform. 33, 403-413. doi: 10.1002/minf.201400024
131. Willett, P., Barnard, J. M., and Downs, G. M. (1998). Chemical similarity searching. J. Chem. Inf. Comp. Sci. 38, 983-996. doi: 10.1021/ci9800211
132. Winter, G. E., Radic, B., Mayor-Ruiz, C., Blomen, V. A., Trefzer, C., Kandasamy, R. K., et al. (2014). The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity. Nat. Chem. Biol. 10, 768-773. doi: 10.1038/nchembio.1590
133. Wold, S., Sjöström, M., and Eriksson, L. (2001). PLS-regression: a basic tool of chemometrics. Chemometr. Intell. Lab. Syst. 58, 109-130. doi: 10.1016/S0169-7439(01)00155-1
134. You, G., and Morris, M. E. (eds.). (2014). Drug Transporters: Molecular Characterization and Role in Drug Disposition. New York, NY: Wiley.
135. Zhu, X., and Goldberg, A. B. (2009). Introduction to Semi-Supervised Learning. San Rafael, CA: Morgan & Claypool.